NASDAQ:VIVE

Viveve Medical Stock Predictions

etoro logo Buy VIVE
*Your capital is at risk
$0.0002
+0 (+0%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

VIVE Prediction Chart

VIVE Predictions History

Latest community submissions for VIVE.
Predictor Target Session Target Price Result Direction Accuracy Score
JS JS Pro
Apr 21, 2021 $2.70 -99.99% $2.84 X 95.07% 1
Apr 21, 2021 Bullish $2.84 X 1
JS JS Pro
Feb 3, 2021 $3.85 -99.99% $3.80 X 98.68% 2
David Candanedo David Candanedo @DavidCandanedo.191498
Feb 2, 2021 Bullish $3.76 X 0
JS JS Pro
Sep 18, 2020 $0.537 -100.00% $0.546 V 98.39% 0
Adaya Kramer Adaya Kramer @AdayaKramer.174051
Sep 18, 2020 Bullish $0.546 X 0
sander7100 yo bro sander7100 yo bro Pro @sander7100yobro.167552
Aug 31, 2020 $0.592 -100.00% $0.613 V 96.65% 0
JS JS Pro
Aug 31, 2020 $0.609 -100.00% $0.613 V 99.35% 3
iHustle84 iHustle84 Pro
Aug 31, 2020 $0.600 -100.00% $0.613 V 97.96% 0
Audrew D Audrew D @AudrewD.172564
Aug 31, 2020 Bullish $0.613 X 1
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for VIVE with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT VIVEVE MEDICAL INC
Viveve Medical
Viveve Medical, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices for the non-invasive treatment of vaginal introital laxity, sexual function, vaginal rejuvenation, and stress urinary incontinence. The company offers Viveve System comprises of the radiofrequency generator, reusable handpiece, and treatment tip, as well as cryogen canister and other consumable components. It markets its products thr...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE